Nuclear Bone Scintigraphy (NBS): A Valuable Tool Depicting Osseointegration at the Sites of Dental Grafts

Abstract:

Hydroxyapatite (HA) implants were used as grafting materials to fill some of the root resections in three patients. Two of the patients had previous root resections without implant insertion. Being implanted to the resection sites, the porous structure of HA serves as a framework for vascular and soft tissue ingrowth. Previous reports on the utilization of three phase nuclear bone scintigraphy (NBS) to evaluate the degree of fibrovascular ingrowth into HA dental implants after surgery are scarce. Three cases are described in which bone scintigraphy was performed at 6 months after implant insertion. The images revealed technetium-99m methylenediphosphonate (99mTc-MDP) uptake at dental implant sites consistent with vascularization and osteoconduction. The current results strongly indicate that osseointegration is complete. This study demonstrates that NBS is a valuable test in the follow up of osseointegration rate at implantation sites and HA is found to be a good biomaterial for grafting purposes showing high osseointegration rates.

• Periodical: Key Engineering Materials (Volumes 309-311)
• Pages: 1393-1396
• DOI: https://doi.org/10.4028/www.scientific.net/KEM.309-311.1393
• Online since: May 2006
• Authors: Faik Nuzhet Oktar, H.T. Turoglu, F. Uzum Yenici, S. Altıntaş
• Keywords: Bone Scintigraphy, Hydroxyapatite Grafting, Osseointegration, Root Resection

References

[1] A.M. Rashmir-Raven, D.C. Richardson and et al.: J. App. Biomater. Vol. 6 (1995), p.237.

[2] H. Oonishi, S. Kushitani andet al.: Clin. Ortho. Rel. Res. No. 334 (1997), p.316.

[3] G.A. Zarb and T. Albrektsson: Int. J. Periodont. Rest. Dent. Vol. 11 (1991), p.88.

[4] F.G. Larson: Med. Dev. Diag. Ind. Mag. Vol. 16 (1994), p.34.

[5] Z. Meidan, S. Weisman and et al.: J. Periodont. Vol. 65 (1994), p.330.

[6] L.M. Numerow, R. Kloiber and et al.: Clin. Nuc. Med . Vol. 19 (1994), p.9.

[7] J.J. Dutton: Ophth. Vol. 98 (1991), p.370.

[8] G.B. Saha. Uses of radiopharmaceuticals in nuclear medicine. In: GB Saha (ed). Fundamentals of nuclear pharmacy, 3rd edition. New York: Springer - Verlag New York Inc.; 1992: 227-304.

DOI: 10.1007/978-1-4757-4027-1_12

[9] S.B. Christensen and C.C. Arnoldi: J. Bone Joint Surg. Vol. 62-A (1980), p.90.

[10] S.B. Christensen and O.W. Krogsgaard: J. Nuc. Med. Vol. 22 (1981), p.237.

[11] P.J. Ferrone and J.J. Dutton: Ophth. Vol. 99 (1992), p.376.

[12] A.C. Civelek, E.M. Pacheco and et al.: Clin. Nuc. Med. Vol. 20 (1995), p.779.